Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cloricromen

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cloricromen in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(cloricromen)
Trials
(cloricromen)
Recent Studies (post-2010) (cloricromen)
9,1561875527131

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A1
de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F1
Francescangeli, E; Goracci, G; Gresele, P; Mezzasoma, AM; Nenci, GG; Prosdocimi, M; Ribaldi, E1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cloricromen

ArticleYear
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
    European journal of pharmacology, 1986, Aug-22, Volume: 128, Issue:1-2

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles

1986
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Thrombosis research, 1985, Aug-15, Volume: 39, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2

1985
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    British journal of pharmacology, 1996, Volume: 118, Issue:6

    Topics: Acetyltransferases; Calcimycin; Chromonar; Diacylglycerol Cholinephosphotransferase; Enzyme Activation; Humans; In Vitro Techniques; Indicators and Reagents; Ionophores; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors

1996